|
GTBP Gt Biopharma Inc 109657 |
| Income Statement |
|
Net Income
|
form10-q
|
-3,411,000 |
| Balance Sheet |
|
Current Assets
|
6,759,000 |
|
Assets
|
6,759,000 |
|
Current Liabilities
|
4,662,000 |
|
Liabilities
|
4,662,000 |
|
Equity
|
2,097,000 |
|
Shares Out
|
2,234,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-10,436,000 |
|
Investing Cash Flow
|
12,892,000 |
| Market Analysis |
Market Cap
|
4,759,346 |
|
Price
|
2.39 |
|
BVPS
|
0.94 |
|
PB
|
2.56 |
|
EPS
|
-7.72 |
|
PS
|
0.14 |
|
FCF
|
2,456,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GTBP documents filed with the SEC.
GTBP Filings
Clear
